Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Booster Immunization of Two COVID-19 Vaccines
NCT05886790Unknown
- Sponsor
- Zhongnan Hospital of Wuhan University
- Start
- May 2023
- Primary completion
- Dec 2023
- Modality
- Viral Vectors, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised, open-label trial of ad5-ncov in coronavirus disease 2019 (COVID-19) (3 arms), sponsored by Zhongnan Hospital of Wuhan University. Primary endpoints: Anti-XBB-specific neutralizing antibody at Day 28 and The incidence of adverse reactions at Day 28. Status: unknown.
02
Drugs
ad5-ncov
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05886790.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05886790.